Terminal
Stocks
Spotlight
News

Stocks
Healthcare
NASDAQ
LSTA

Market Cap: $16.03M

LI

Lisata Therapeutics, Inc.

LSTA

NASDAQ (NASDAQ Capital Market)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

Cashu

Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Cashu Markets Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin95.00%

EBITDA Margin-160.07%

EBIT Margin-160.71%

Pre-tax Margin-150.08%

Net Profit Margin-146.21%

Earnings Yield-91.23%

Valuation Multiples

Price / Book1.94

Price / Sales160.27

Price / Earnings-1.07

PEG-0.03

Forward PEG-0.17

EV / Sales55.84

EV / EBITDA-0.35

EV / Operating Cash Flow-0.45

EV / Free Cash Flow-0.45

Price / Free Cash Flow-1.30

Price / Operating Cash Flow-1.30

Cash Flow & Capital

Free Cash Flow / Share-$1.35

Operating Cash Flow / Share-$1.35

Free Cash Flow Yield-76.89%

Capex / Revenue0.00%

Capex / Operating Cash Flow0.00%

Capex / Depreciation0.00

Stock Compensation / Revenue10.35%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio3.69

Quick Ratio3.69

Cash Ratio3.50

Debt / Assets0.00

Debt / Capital0.00

Debt / Equity0.00

Long-Term Debt / Capital0.00

Debt / Market Cap0.00%

Net Debt / EBITDA0.65

Solvency Ratio-4.79

Financial Leverage1.34

Efficiency & Working Capital

Asset Turnover0.01

Fixed Asset Turnover7.14

Inventory Turnover0.00

Receivables Turnover0.50

Payables Turnover0.01

Days Sales Outstanding730

Days Inventory Outstanding0

Days Payables Outstanding61,028

Operating Cycle730

Cash Conversion Cycle-60,298

Working Capital Turnover0.01

Returns & Quality

Return on Equity-1.14%

Return on Assets-1.33%

Return on Invested Capital-1.99%

ROCE-2.04%

Return on Tangible Assets-1.33%

Operating Return on Assets-1.31%

Income Quality0.84

Tax Burden0.97

Interest Burden0.93

Balance Sheet & Intrinsic Metrics

Enterprise Value$5.58M

Invested Capital$8.04M

Working Capital$8.03M

Tangible Asset Value$7.99M

Net Current Asset Value$7.98M

Graham Net-Net$0.83

Book Value / Share$0.88

Tangible Book Value / Share$0.88

Cash / Share$1.15

Financial Health Scores

Piotroski Score1

Altman Z-Score-73.77

Revenue$100K

EBIT$-16.07M

Market Cap$14.11M

Working Capital$8.03M

Retained Earnings$-572.07M

Total Assets$11.03M

Total Liabilities$3.04M